SecBot SecBot
3 ·Filed Jun 1, 2026

OKYO

OKYO Pharma Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001493152-26-026688
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Routine Form 3 filing — no trading signal. Monitor for any subsequent Form 4 filings that might indicate insider buying or selling activity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
OKYO ▼ -8.82% at T+60d
NEUTRAL call -8.82% · α vs SPY -9.94% · entry $1.70 → $1.55
Entry = T+0 close
Jun 1, 2026
via day close
T+1d
-2.35%
call -2.35% · α -1.63%
$1.66
settled 5mo ago
T+5d
-9.41%
call -9.41% · α -6.45%
$1.54
settled 5mo ago
T+20d
-11.76%
call -11.76% · α -10.20%
$1.50
settled 4mo ago
T+60d
-8.82%
call -8.82% · α -9.94%
$1.55
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Form 3 filing by director Simon Willy Jules discloses initial beneficial ownership in OKYO Pharma Ltd, including 6,435 shares held directly and 8,948 shares held by spouse, along with multiple tranches of stock options exercisable at prices ranging from $1.46 to $2.13. This is a routine initial ownership disclosure with no material financial impact.

Key Facts

  • Simon Willy Jules filed Form 3 as a director of OKYO Pharma Ltd on 2026-06-01, reporting ownership as of 2026-03-18.
  • Direct holdings: 6,435 shares of common stock.
  • Indirect holdings: 8,948 shares held by spouse.
  • Options held: multiple tranches with exercise prices of $1.46, $1.50, $1.60, $1.65, and $2.13, expiring between 2033 and 2035.
  • Total option shares: approximately 125,000+ across all tranches (sum of individual tranches).

Financial Impact

No financial impact; routine initial ownership disclosure.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001493152-26-026688
Document: 0001493152-26-026688-index.html0001493152-26-026688
Document: 0001493152-26-026688.txt0001493152-26-026688
29 reports for OKYO
Performance horizon
50% Hit rate @ T+1 5 of 10 directional calls Went positive at some point 7 of 10 best @ T+5▲ +13.89%Jul 21, 2026
Filters
Rows
Reports for OKYO — sortable, filterable
TypeNow
Oct 6, 2026
21d ago
6-K
BULLISH ★ 6/10
$1.46 $1.41▼ −3.42%▼ −3.18%$1.49 (+2.05%)
Oct 6, 2026
21d ago
Press Release
BULLISH ★ 6/10
$1.46 $1.41▼ −3.42%▼ −3.18%$1.49 (+2.05%)
Sep 29, 2026
28d ago
6-K
NEUTRAL ★ 3/10
$1.36 $1.29▼ −5.15%▼ −4.94%$1.49 (+9.56%)
Sep 8, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$1.53 $1.45▼ −5.23%▼ −4.76%$1.49 (−2.61%)
Aug 7, 2026
11w ago
Insider Cluster
BULLISH ★ 5/10
$1.57 $1.52▼ −3.18%▼ −2.87%$1.49 (−5.10%)
Jul 28, 2026
13w ago
6-K
NEUTRAL ★ 3/10
$1.64 $1.64· 0.00%▲ +1.54%$1.49 (−9.15%)
Jul 27, 2026
13w ago
6-K
NEUTRAL ★ 2/10
$1.64 $1.64· 0.00%▼ −0.24%$1.49 (−9.15%)
Jul 23, 2026
13w ago
6-K
NEUTRAL ★ 2/10
$1.48 $1.55▲ +4.73%▲ +4.63%$1.49 (+0.68%)
Jul 23, 2026
13w ago
Press Release
NEUTRAL ★ 2/10
$1.48 $1.55▲ +4.73%▲ +4.63%$1.49 (+0.68%)
Jul 23, 2026
13w ago
6-K
BULLISH ★ 4/10
$1.48 $1.55▲ +4.73%▲ +4.63%$1.49 (+0.68%)
Showing 10 of 29

US Market Status

Market Closed — Opens Thu (9h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 1, 2026